Search Results - "Shumskaya, Irina S."

Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine by Sokolova, Tatiana N, Breder, Valeriy V, Shumskaya, Irina S, Suspitsin, Evgeny N, Aleksakhina, Svetlana N, Yanus, Grigoriy A, Tiurin, Vladislav I, Ivantsov, Alexandr O, Vona, Barbara, Raskin, Grigoriy A, Gamajunov, Sergey V, Imyanitov, Evgeny N

“…Many cancer patients undergo sophisticated laboratory testing, which requires proper interpretation and interaction between different specialists. We describe…”
Get full text

The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia by Sokolova, Tatiana N., Aleksakhina, Svetlana N., Yanus, Grigoriy A., Sultanbaev, Aleksandr V., Menshikov, Konstantin V., Lysenko, Anna N., Zukov, Ruslan A., Zyuzyukina, Alena V., Murunova, Yulia N., Rossokha, Elena I., Bakharev, Sergey Y., Basova, Elena A., Kasmynina, Tatiana A., Shumskaya, Irina S., Bakshun, Yana I., Musaeva, Khedi S., Khasanova, Alfia I., Dmitriev, Vadim N., Bolieva, Marina B., Gadzaova, Christina H., Petrenko, Oleg L., Maksimov, Dmitriy A., Vladimirov, Vladimir I., Goldberg, Viktor E., Popova, Nataliya O., Kibisheva, Marianna V., Khamgokov, Zaur M., Vasilyev, Alexey E., Iyevleva, Aglaya G., Imyanitov, Evgeny N.

“…Relevance. PIK3CA belongs to the top three most frequently mutated genes in breast cancer (BC), especially in estrogen receptor (ER) positive, HER2 negative BC…”
Get full text

Perioperative chemotherapy and morphological response in the treatment of gastric cancer: A retrospective study by Kiselev, Nikolay M., Klimin, Sergey A., Kolesnik, Yan I., Kokorin, Roman S., Ashimov, Erkin А., Elagina, Victoria Y., Shumskaya, Irina S., Zagainov, Vladimir E., Gamayunov, Sergey V.

“…Aim. To analyze the treatment (8 cycle FLOT + surgery) to search for predictors of tumor pathomorphosis, assess the impact of chemotherapy on treatment…”
Get full text

Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study by Sokolova, Tatyana N., Solov'eva, Tatyana I., Aleksakhina, Svetlana N., Bolieva, Marina B., Goldberg, Viktor E., Kibisheva, Marianna V., Menshikov, Konstantin V., Ryazanov, Dmitrii V., Shkradyuk, Aleksandr V., Chapko, Yana S., Shchukina, Anna A., Khabriev, Idris M., Kirtbaya, Dmitrii V., Degtyarev, Alexey M., Epkhiev, Aleksandr A., Tyugina, Yana A., Togo, Aleksandr V., Murachuev, Mirza A., Ievleva, Aglaya G., Imyanitov, Evgenii N., Grechkina, Anna A., Stel'makh, Alena S., Odintsova, Svetlana V., Janus, Grigorii A., Musaeva, Khedi S., Chang, Victor L., Fateeva, Anastasia V., Startseva, Ekaterina P., Popova, Nataliya O., Mikheeva, Yulia V., Vasilevskaya, Anna V., Barbara, Victoria S., Khabibulaeva, Petimat I., Khlobystina, Alina G., Bembeeva, Ludmila V., Vladimirov, Vladimir I., Petrenko, Oleg L., Ruskova, Natalia G., Serikova, Ekaterina L., Subbotina, Ksenia S., Tkachenko, Svetlana A., Yukalchuk, Denis Y., Basova, Elena A., Stepanova, Mariya L., Erdniev, Sanal P., Goryainova, Alla, Gluzman, Mark I., Orlova, Rashida V., Stukan, Anastasiya I., Zukov, Ruslan A., Zyuzyukina, Alena V., Murunova, Yulia N., Sultanbaev, Aleksandr V., Vorobeva, Elena N., Mikhaevich, Leonid M., Lysenko, Anna N., Khachmamuk, Zarema K., Kozlov, Andrey E., Bakharev, Sergey Y., Pyliv, Victoria N., Amirkhanova, Irina K., Parsyan, Shahen G., Rossokha, Elena I., Osidze, Leri D., Shumskaya, Irina S., Agaeva, Anna V., Kasmynina, Tatiana A., Klimenko, Veronika V., Akhmetgareeva, Kamila T., Vakhitova, Almira A., Chakhkieva, Madina D., Udalova, Yana A., Dmitriev, Vadim N., Bakshun, Yana I., Vasilyev, Alexey E., Gasimly, Dunya D, Kravchenko, Nadezhda A., Maksimov, Dmitriy A., Nesterova, Alfia I., Khamgokov, Zaur M., Sharvashidze, Ineza O., Gadzaova, Christina H., Rakhmankulova, Galina G., Shvaiko, Kseniya A.

“…Background. By 2020, breast cancer (BC) has become the most frequent malignancy in the world. The most common type of BC is HR+/HER2-negative cancer,2540% of…”
Get full text